Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Italian scientists discover new selective androgen receptor modulators

Nov. 16, 2010

Nektar Therapeutics presents new tyrosine protein kinase inhibitor-oligomer conjugates

Nov. 16, 2010

AB Therapeutics reports data on two anticancer agents in model of NSCLC

Nov. 16, 2010

Epeius Biotech gets U.S. federal grant to further develop Rexin-G

Nov. 15, 2010

Eisai claims novel cytidine deaminase inhibitors

Nov. 15, 2010

Wyeth discovers new inhibitors of PI3K-alpha and mTOR

Nov. 15, 2010

EMA committee recommends orphan drug status for ThermoDox in primary liver cancer

Nov. 12, 2010

CytRx begins pharmacokinetic bafetinib trial in patients with brain cancer

Nov. 12, 2010

Canadian scientists identify new antimitotic agents

Nov. 12, 2010

Novel mTOR inhibitors presented by Merck & Co.

Nov. 12, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...